GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PTC Therapeutics Inc (FRA:BH3) » Definitions » Marketable Securities

PTC Therapeutics (FRA:BH3) Marketable Securities : €343.8 Mil (As of Dec. 2024)


View and export this data going back to 2013. Start your Free Trial

What is PTC Therapeutics Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. PTC Therapeutics's Marketable Securities for the quarter that ended in Dec. 2024 was €343.8 Mil.

PTC Therapeutics's annual Marketable Securities increased from Dec. 2022 (€123.5 Mil) to Dec. 2023 (€259.3 Mil) and increased from Dec. 2023 (€259.3 Mil) to Dec. 2024 (€343.8 Mil).

PTC Therapeutics Marketable Securities Historical Data

The historical data trend for PTC Therapeutics's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PTC Therapeutics Marketable Securities Chart

PTC Therapeutics Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 735.56 516.54 123.54 259.27 343.79

PTC Therapeutics Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 259.27 309.54 407.38 439.11 343.79

PTC Therapeutics Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

PTC Therapeutics  (FRA:BH3) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

PTC Therapeutics Marketable Securities Related Terms

Thank you for viewing the detailed overview of PTC Therapeutics's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

PTC Therapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PTC Therapeutics Inc (FRA:BH3) » Definitions » Marketable Securities
Comparable Companies
RYTM RNA SLNO ZLAB RARE PCVX ACLX SWTX CRSP AKRO VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
PTCT:USA
Address
500 Warren Corporate Center Drive, Warren, NJ, USA, 07059
Website
https://www.ptcbio.com
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.

PTC Therapeutics Headlines

No Headlines